Polycystic ovary syndrome: Effect and mechanisms of acupuncture for ovulation induction

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Johansson, Julia ^a   Stener Victorin, Elisabet ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; NALOXONE; NALTREXONE;

ACUPUNCTURE; AMENORRHEA; ANOVULATION; CLINICAL TRIAL; DRUG MEGADOSE; FEMALE INFERTILITY; HUMAN; HYPERANDROGENISM; MENSTRUATION DISORDER; MYALGIA; NONHUMAN; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SENSORY NERVE; STEROIDOGENESIS;

EID: 84885341649     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/762615     Document Type: Review

References (194)

1. Yildiz B. O., Bozdag G., Yapici Z., Esinler I., Yarali H., Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Human Reproduction 2012 27 3067 3073
2. March W. A., Moore V. M., Willson K. J., Phillips D. I. W., Norman R. J., Davies M. J., The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction 2010 25 2 544 551 2-s2.0-74549160893 10.1093/humrep/dep399
3. Wild R. A., Carmina E., Diamanti-Kandarakis E., Dokras A., Escobar-Morreale H. F., Futterweit W., Lobo R., Norman R. J., Talbott E., Dumesic D. A., Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. The Journal of Clinical Endocrinology and Metabolism 2010 95 5 2038 2049 2-s2.0-77952787136 10.1210/jc.2009-2724
4. Sathyapalan T., Atkin S. L., Recent advances in cardiovascular aspects of polycystic ovary syndrome. European Journal of Endocrinology 2012 166 4 575 583 2-s2.0-84859406194 10.1530/EJE-11-0755
5. (NIH) NIoH, Evidence-Based Methodology Workshop on Polycystic Ovary Syndrome 2012
6. Sir-Petermann T., Codner E., Pérez V., Echiburú B., Maliqueo M., De Guevara A. L., Preisler J., Crisosto N., Sánchez F., Cassorla F., Bhasin S., Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 2009 94 6 1923 1930 2-s2.0-66749176714 10.1210/jc.2008-2836
7. Franks S., Adult polycystic ovary syndrome begins in childhood. Best Practice and Research 2002 16 2 263 272 2-s2.0-0036034768 10.1053/beem.2002.0203
8. Witchel S. F., Puberty and polycystic ovary syndrome. Molecular and Cellular Endocrinology 2006 254-255 146 153 2-s2.0-33745917108 10.1016/j.mce.2006.04.028 (Pubitemid 44041765)
9. Stepto N. K., Cassar S., Joham A. E., Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Human Reproduction 2013 28 3 777 784 10.1093/humrep/des463
10. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H. F., Futterweit W., Janssen O. E., Legro R. S., Norman R. J., Taylor A. E., Witchel S. F., Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. The Journal of Clinical Endocrinology and Metabolism 2006 91 11 4237 4245 2-s2.0-33751526500 10.1210/jc.2006-0178 (Pubitemid 44833391)
11. Stener-Victorin E., Holm G., Labrie F., Nilsson L., Janson P. O., Ohlsson C., Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome? The Journal of Clinical Endocrinology and Metabolism 2010 95 2 810 819 2-s2.0-76149127645 10.1210/jc.2009-1908
12. Nisenblat V., Norman R. J., Androgens and polycystic ovary syndrome. Current Opinion in Endocrinology, Diabetes and Obesity 2009 16 3 224 231 2-s2.0-66349091127 10.1097/MED.0b013e32832afd4d
13. Pasquali R., Casimirri F., The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clinical Endocrinology 1993 39 1 1 16 2-s2.0-0027214646 (Pubitemid 23212875)
14. Pache T. D., Chadha S., Gooren L. J. G., Hop W. C. J., Jaarsma K. W., Dommerholt H. B. R., Fauser B. C. J. M., Ovarian morphology in long-term androgen-treated female to male transsexuals. A human mode for the study of polycystic ovarian syndrome? Histopathology 1991 19 5 445 452 2-s2.0-0025945050
15. Elbers J. M. H., Giltay E. J., Teerlink T., Scheffer P. G., Asscheman H., Seidell J. C., Gooren L. J. G., Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clinical Endocrinology 2003 58 5 562 571 2-s2.0-0038670755 10.1046/j.1365-2265.2003.01753.x (Pubitemid 36566798)
16. Franks S., Do animal models of polycystic ovary syndrome help to understand its pathogenesis and management? Yes, but their limitations should be recognized. Endocrinology 2009 150 9 3983 3985 2-s2.0-69249132998 10.1210/en.2009-0652
17. Abbott D. H., Tarantal A. F., Dumesic D. A., Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. American Journal of Primatology 2009 71 9 776 784 2-s2.0-69349084968 10.1002/ajp.20679
18. Manikkam M., Thompson R. C., Herkimer C., Welch K. B., Flak J., Karsch F. J., Padmanabhan V., Developmental programming: impact of prenatal testosterone excess on pre- and postnatal gonadotropin regulation in sheep. Biology of Reproduction 2008 78 4 648 660 2-s2.0-41549136181 10.1095/biolreprod.107.063347 (Pubitemid 351469344)
19. Hogg K., Young J. M., Oliver E. M., Souza C. J., McNeilly A. S., Duncan W. C., Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome. Endocrinology 2012 153 1 450 461 2-s2.0-84455188274 10.1210/en.2011-1607
20. Sir-Petermann T., Maliqueo M., Angel B., Lara H. E., Përez-Bravo F., Recabarren S. E., Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Human Reproduction 2002 17 10 2573 2579 2-s2.0-0036796149 (Pubitemid 35174106)
21. Barry J. A., Kay A. R., Navaratnarajah R., Iqbal S., Bamfo J. E. A. K., David A. L., Hines M., Hardiman P. J., Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. Journal of Obstetrics and Gynaecology 2010 30 5 444 446 2-s2.0-77954478324 10.3109/01443615.2010.485254
22. Mannerås L., Cajander S., Holmäng A., Seleskovic Z., Lystig T., Lönn M., Stener-Victorin E., A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 2007 148 8 3781 3791 2-s2.0-34547138420 10.1210/en.2007-0168 (Pubitemid 47105840)
23. Stener-Victorin E., Ploj K., Larsson B.-M., Holmäng A., Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity. Reproductive Biology and Endocrinology 2005 3, article 44 2-s2.0-27344440648 10.1186/1477-7827-3-44 (Pubitemid 41522392)
24. van Houten E. L., Kramer P., McLuskey A., Reproductive and metabolic phenotype of a mouse model of PCOS. Endocrinology 2012 153 2861 2869
25. Fauser B. C. J. M., Tarlatzis B. C., Rebar R. W., Legro R. S., Balen A. H., Lobo R., Carmina E., Chang J., Yildiz B. O., Laven J. S. E., Boivin J., Petraglia F., Wijeyeratne C. N., Norman R. J., Dunaif A., Franks S., Wild R. A., Dumesic D., Barnhart K., Consensus on women's health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility 2012 97 1 28.e25 38.e25 2-s2.0-84155163090 10.1016/j.fertnstert.2011.09.024
26. Schüring A. N., Schulte N., Sonntag B., Kiesel L., Androgens and insulin-two key players in polycystic ovary syndrome: recent concepts in the pathophysiology and genetics of polycystic ovary syndrome. Gynakologisch- Geburtshilfliche Rundschau 2008 48 1 9 15 2-s2.0-38549123824 10.1159/000111465 (Pubitemid 351154915)
27. Lim S. S., Norman R. J., Davies M. J., Moran L. J., The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obesity Reviews 2012 14 2 95 109 10.1111/j.1467-789X.2012.01053.x.
28. Franks S., McCarthy M. I., Hardy K., Skakkebæk N. E., Aitken R. J., Swan S., De Muinck Keizer-Schrama S., Development of polycystic ovary syndrome: involvement of genetic and environmental factors. International Journal of Andrology 2006 29 1 278 285 2-s2.0-33645217979 10.1111/j.1365-2605.2005.00623.x
29. Abbott D. H., Dumesic D. A., Franks S., Developmental origin of polycystic ovary syndrome-a hypothesis. Journal of Endocrinology 2002 174 1 1 5 2-s2.0-0036313064 10.1677/joe.0.1740001 (Pubitemid 34830927)
30. Sverrisdóttir Y. B., Mogren T., Kataoka J., Janson P. O., Stener-Victorin E., Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? American Journal of Physiology 2008 294 3 E576 E581 2-s2.0-40449140552 10.1152/ajpendo.00725.2007 (Pubitemid 351355228)
31. Balen A. H., Hypersecretion of luteinizing hormone and the polycystic ovary syndrome. Human Reproduction 1993 8 supplement 2 123 128 2-s2.0-0027504772 (Pubitemid 23337190)
32. Burt Solorzano C. M., Beller J. P., Abshire M. Y., Collins J. S., McCartney C. R., Marshall J. C., Neuroendocrine dysfunction in polycystic ovary syndrome. Steroids 2012 77 4 332 337 2-s2.0-84857061698 10.1016/j.steroids.2011. 12.007
33. Blank S. K., McCartney C. R., Marshall J. C., The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Human Reproduction Update 2006 12 4 351 361 2-s2.0-33745249573 10.1093/humupd/dml017 (Pubitemid 43923410)
34. Blank S. K., McCartney C. R., Helm K. D., Marshall J. C., Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Seminars in Reproductive Medicine 2007 25 5 352 359 2-s2.0-34548309030 10.1055/s-2007-984741 (Pubitemid 47339159)
35. Rebar R., Judd H. L., Yen S. S., Rakoff J., Vandenberg G., Naftolin F., Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. Journal of Clinical Investigation 1976 57 5 1320 1329 2-s2.0-0017068476
36. Arroyo A., Laughlin G. A., Morales A. J., Yen S. S. C., Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. The Journal of Clinical Endocrinology and Metabolism 1997 82 11 3728 3733 2-s2.0-0030698381 (Pubitemid 27509362)
37. Waldstreicher J., Santoro N. F., Hall J. E., Filicori M., Crowley W. F. Jr., Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. The Journal of Clinical Endocrinology and Metabolism 1988 66 1 165 172 2-s2.0-0023870461 (Pubitemid 18027747)
38. Cheung A. P., Lu J. K. H., Chang R. J., Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment. Human Reproduction 1997 12 6 1156 1164 2-s2.0-0031008234 (Pubitemid 27273536)
39. Patel K., Coffler M. S., Dahan M. H., Malcom P. J., Deutsch R., Chang R. J., Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome. Clinical Endocrinology 2004 60 1 67 74 2-s2.0-0842265978 10.1111/j.1365-2265. 2004.01945.x (Pubitemid 38183500)
40. Hayes F. J., Taylor A. E., Martin K. A., Hall J. E., Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics. The Journal of Clinical Endocrinology and Metabolism 1998 83 7 2343 2349 2-s2.0-0031728153 10.1210/jc.83.7.2343 (Pubitemid 28503025)
41. Pastor C. L., Griffin-Korf M. L., Aloi J. A., Evans W. S., Marshall J. C., Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. The Journal of Clinical Endocrinology and Metabolism 1998 83 2 582 590 2-s2.0-0031765313 10.1210/jc.83.2.582 (Pubitemid 28496543)
42. Eagleson C. A., Gingrich M. B., Pastor C. L., Arora T. K., Burt C. M., Evans W. S., Marshall J. C., Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. The Journal of Clinical Endocrinology and Metabolism 2000 85 11 4047 4052 2-s2.0-0034523425 10.1210/jc.85.11.4047 (Pubitemid 32055351)
43. Daniels T. L., Berga S. L., Resistance of gonadotropin releasing hormone drive to sex steroid- induced suppression in hyperandrogenic anovulation. The Journal of Clinical Endocrinology and Metabolism 1997 82 12 4179 4183 2-s2.0-0030735282 (Pubitemid 27525536)
44. Genazzani A. D., Strucchi C., Luisi M., Casarosa E., Lanzoni C., Baraldi E., Ricchieri F., Mehmeti H., Genazzani A. R., Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome. Gynecological Endocrinology 2006 22 1 36 43 2-s2.0-33644829248 10.1080/09513590500476164 (Pubitemid 43355096)
45. Blank S. K., McCartney C. R., Chhabra S., Helm K. D., Eagleson C. A., Chang R. J., Marshall J. C., Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls-implications for regulation of pubertal maturation. The Journal of Clinical Endocrinology and Metabolism 2009 94 7 2360 2366 2-s2.0-67650269904 10.1210/jc.2008-2606
46. Tosi F., Negri C., Perrone F., Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 2012 97 1712 1719
47. Jonard S., Dewailly D., The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Human Reproduction Update 2004 10 2 107 117 2-s2.0-1942537089 10.1093/humupd/dmh010 (Pubitemid 38519332)
48. Franks S., Stark J., Hardy K., Follicle dynamics and anovulation in polycystic ovary syndrome. Human Reproduction Update 2008 14 4 367 378 2-s2.0-45549108109 10.1093/humupd/dmn015 (Pubitemid 351858976)
49. Millier S. G., Whitelaw P. F., Smyth C. D., Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited. Molecular and Cellular Endocrinology 1994 100 1-2 51 54 2-s2.0-0028333722 10.1016/0303- 7207(94)90278-X (Pubitemid 24109526)
50. Magoffin D. A., Ovarian theca cell. International Journal of Biochemistry & Cell Biology 2005 37 7 1344 1349 2-s2.0-17044370782 10.1016/j.biocel. 2005.01.016
51. Nelson V. L., Legro R. S., Strauss J. F. III, McAllister J. M., Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Molecular Endocrinology 1999 13 6 946 957 2-s2.0-0033304623 (Pubitemid 30645312)
52. Almog B., Shehata F., Suissa S., Holzer H., Shalom-Paz E., La Marca A., Muttukrishna S., Blazar A., Hackett R., Nelson S. M., Cunha-Filho J. S., Eldar-Geva T., Margalioth E. J., Raine-Fenning N., Jayaprakasan K., McIlveen M., Wunder D., Freour T., Nardo L. G., Balasch J., Peñarrubia J., Smeenk J., Gnoth C., Godehardt E., Lee T.-H., Lee M.-S., Levin I., Gamzu R., Tulandi T., Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study. Fertility and Sterility 2011 95 7 2359.e1 2363.e1 2-s2.0-79956358262 10.1016/j.fertnstert.2011.02.057
53. Seifer D. B., Baker V. L., Leader B., Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertility and Sterility 2011 95 2 747 750 2-s2.0-78751585466 10.1016/j.fertnstert.2010.10.011
54. Durlinger A. L. L., Gruijters M. J. G., Kramer P., Karels B., Kumar T. R., Matzuk M. M., Rose U. M., De Jong F. H., Uilenbroek J. T. J., Grootegoed J. A., Themmen A. P. N., Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001 142 11 4891 4899 2-s2.0-17944381620 10.1210/en.142.11.4891 (Pubitemid 33022365)
55. Durlinger A. L. L., Kramer P., Karels B., De Jong F. H., Uilenbroek J. T. J., Anton Grootegoed J., Themmen A. P. N., Control of primordial follicle recruitment by anti-mullerian hormone in the mouse ovary. Endocrinology 1999 140 12 5789 5796 2-s2.0-0033305425 (Pubitemid 30645368)
56. Durlinger A. L. L., Gruijters M. J. G., Kramer P., Karels B., Ingraham H. A., Nachtigal M. W., Uilenbroek J. T. J., Anton Grootegoed J., Themmen A. P. N., Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002 143 3 1076 1084 2-s2.0-0036171566 10.1210/en.143.3.1076 (Pubitemid 34164056)
57. Stubbs S. A., Hardy K., Da Silva-Buttkus P., Stark J., Webber L. J., Flanagan A. M., Themmen A. P. N., Visser J. A., Groome N. P., Franks S., Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. The Journal of Clinical Endocrinology and Metabolism 2005 90 10 5536 5543 2-s2.0-26244468712 10.1210/jc.2005-0907 (Pubitemid 41415455)
58. Moran L. J., Noakes M., Clifton P. M., Norman R. J., The use of anti-müllerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 2007 92 10 3796 3802 2-s2.0-35348965687 10.1210/jc.2007-1188 (Pubitemid 47607625)
59. Thomson R. L., Buckley J. D., Moran L. J., Noakes M., Clifton P. M., Norman R. J., Brinkworth G. D., The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment. Human Reproduction 2009 24 8 1976 1981 2-s2.0-67651123055 10.1093/humrep/dep101
60. Franasiak J., Young S. L., Williams C. D., Pastore L. M., Longitudinal anti-mullerian hormone in women with polycystic ovary syndrome: an acupuncture randomized clinical trial. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 973712 10.1155/2012/973712
61. Fallat M. E., Siow Y., Marra M., Cook C., Carrillo A., Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertility and Sterility 1997 67 5 962 965 2-s2.0-0030611756 10.1016/S0015-0282(97)81417-3 (Pubitemid 27183931)
62. Cook C. L., Siow Y., Brenner A. G., Fallat M. E., Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertility and Sterility 2002 77 1 141 146 2-s2.0-0036153430 10.1016/S0015-0282(01)02944-2 (Pubitemid 34093906)
63. Falbo A., Rocca M., Russo T., D'Ettore A., Tolino A., Zullo F., Orio F., Palomba S., Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin. Journal of Ovarian Research 2010 3 1, article 16 2-s2.0-77955259491 10.1186/1757-2215-3-16
64. Pigny P., Merlen E., Robert Y., Cortet-Rudelli C., Decanter C., Jonard S., Dewailly D., Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. The Journal of Clinical Endocrinology and Metabolism 2003 88 12 5957 5962 2-s2.0-0242479340 10.1210/jc.2003-030727 (Pubitemid 38033078)
65. Crisosto N., Sir-Petermann T., Greiner M., Maliqueo M., Moreno M., Aedo P., Lara H. E., Testosterone-induced downregulation of anti-Müllerian hormone expression in granulosa cells from small bovine follicles. Endocrine 2009 36 2 339 345 2-s2.0-73349115872
66. Chand A. L., Harrison C. A., Shelling A. N., Inhibin and premature ovarian failure. Human Reproduction Update 2010 16 1 39 50 2-s2.0-77449144330 10.1093/humupd/dmp031
67. Torgac M., Kokcu A., Cetinkaya M. B., Alper T., Malatyalioglu E., Do basal inhibin A and inhibin B levels have value in the diagnosis of polycystic ovary syndrome? Gynecological Endocrinology 2005 20 6 322 326 2-s2.0-22144475475 10.1080/09513590500098125 (Pubitemid 40978803)
68. Chu M. C., Carmina E., Wang J., Lobo R. A., Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B. Fertility and Sterility 2005 84 6 1685 1688 2-s2.0-28944435737 10.1016/j.fertnstert.2005.06.026 (Pubitemid 41785664)
69. Rosencrantz M. A., Wachs D. S., Coffler M. S., Malcom P. J., Donohue M., Chang R. J., Comparison of inhibin B and estradiol responses to intravenous FSH in women with polycystic ovary syndrome and normal women. Human Reproduction 2010 25 1 198 203 2-s2.0-72849114263 10.1093/humrep/dep373
70. Wachs D. S., Coffler M. S., Malcom P. J., Chang R. J., Comparison of follicle-stimulating-hormone-stimulated dimeric inhibin and estradiol responses as indicators of granulosa cell function in polycystic ovary syndrome and normal women. The Journal of Clinical Endocrinology and Metabolism 2006 91 8 2920 2925 2-s2.0-33747688997 10.1210/jc.2006-0442 (Pubitemid 44271736)
71. Welt C. K., Taylor A. E., Fox J., Messerlian G. M., Adams J. M., Schneyer A. L., Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. The Journal of Clinical Endocrinology and Metabolism 2005 90 10 5582 5587 2-s2.0-26244455688 10.1210/jc.2005-0695 (Pubitemid 41415462)
72. Li H. W. R., Anderson R. A., Yeung W. S. B., Ho P. C., Ng E. H. Y., Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea. Fertility and Sterility 2011 96 3 774 779 2-s2.0-80052273986 10.1016/j.fertnstert.2011.06.016
73. Reaven G. M., Lithell H., Landsberg L., Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. The New England Journal of Medicine 1996 334 6 374 381 2-s2.0-0030025673 10.1056/NEJM199602083340607 (Pubitemid 26049592)
74. Lansdown A., Aled Rees D., The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? Clinical Endocrinology 2012 77 6 791 801
75. Greiner M., Paredes A., Araya V., Lara H. E., Role of stress and sympathetic innervation in the development of polycystic ovary syndrome. Endocrine 2005 28 3 319 324 2-s2.0-29944432227 10.1385/ENDO:28:3:319 (Pubitemid 43042731)
76. Sotomayor-Zárate R., Dorfman M., Paredes A., Lara H. E., Neonatal exposure to estradiol valerate programs ovarian sympathetic innervation and follicular development in the adult rat. Biology of Reproduction 2008 78 4 673 680 2-s2.0-41549148359 10.1095/biolreprod.107.063974 (Pubitemid 351469346)
77. Stener-Victorin E., Jedel E., Mannerås L., Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence. Journal of Neuroendocrinology 2008 20 3 290 298 2-s2.0-39549100115 10.1111/j.1365-2826. 2007.01634.x (Pubitemid 351280093)
78. Garcia-Rudaz C., Armando I., Levin G., Escobar M. E., Barontini M., Peripheral catecholamine alterations in adolescents with polycystic ovary syndrome. Clinical Endocrinology 1998 49 2 221 228 2-s2.0-0031827567 10.1046/j.1365-2265.1998.00511.x (Pubitemid 28372652)
79. Heider U., Pedal I., Spanel-Borowski K., Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries. Fertility and Sterility 2001 75 6 1141 1147 2-s2.0-0034989386 10.1016/S0015-0282(01)01805-2 (Pubitemid 32522611)
80. Giallauria F., Palomba S., Manguso F., Vitelli A., Maresca L., Tafuri D., Lombardi G., Colao A., Vigorito C., Orio F., Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. Clinical Endocrinology 2008 68 1 88 93 2-s2.0-36949032306 10.1111/j.1365-2265.2007.03004.x (Pubitemid 350243487)
81. Yildirir A., Aybar F., Kabakci G., Yarali H., Oto A., Heart rate variability in young women with polycystic ovary syndrome. Annals of Noninvasive Electrocardiology 2006 11 4 306 312 2-s2.0-33749866055 10.1111/j.1542-474X. 2006.00122.x (Pubitemid 44564295)
82. Tekin G., Tekin A., Kilicarslan E. B., Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome. International Journal of Cardiology 2008 130 1 49 55
83. Dissen G. A., Garcia-Rudaz C., Paredes A., Mayer C., Mayerhofer A., Ojeda S. R., Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans. Endocrinology 2009 150 6 2906 2914 2-s2.0-66649126063 10.1210/en.2008-1575
84. Walters K. A., Allan C. M., Handelsman D. J., Rodent models for human polycystic ovary syndrome. Biology of Reproduction 2012 86 141 112
85. McNeilly A. S., Colin Duncan W., Rodent models of polycystic ovary syndrome. Molecular and Cellular Endocrinology 2013 373 1-2 2 7
86. Franks S., Animal models and the developmental origins of polycystic ovary syndrome: increasing evidence for the role of androgens in programming reproductive and metabolic dysfunction. Endocrinology 2012 153 2536 2538
87. Puurunen J., Piltonen T., Jaakkola P., Ruokonen A., Morin-Papunen L., Tapanainen J. S., Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 2009 94 6 1973 1978 2-s2.0-66749118939 10.1210/jc.2008-2583
88. Gonzalez F., Chang L., Horab T., Stanczyk F. Z., Crickard K., Lobo R. A., Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome. Fertility and Sterility 1999 71 3 439 444 2-s2.0-0032959034 10.1016/S0015-0282(98)00469-5 (Pubitemid 29094118)
89. Diamanti-Kandarakis E., Papavassiliou A. G., Kandarakis S. A., Chrousos G. P., Pathophysiology and types of dyslipidemia in PCOS. Trends in Endocrinology and Metabolism 2007 18 7 280 285 2-s2.0-34548273096 10.1016/j.tem.2007.07.004 (Pubitemid 47332216)
90. Homburg R., Androgen circle of polycystic ovary syndrome. Human Reproduction 2009 24 7 1548 1555 2-s2.0-69149102104 10.1093/humrep/dep049
91. Mannerås-Holm L., Leonhardt H., Kullberg J., Jennische E., Odén A., Holm G., Hellström M., Lönn L., Olivecrona G., Stener-Victorin E., Lönn M., Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. The Journal of Clinical Endocrinology and Metabolism 2011 96 2 E304 E311 2-s2.0-79951701058 10.1210/jc.2010-1290
92. Dissen G. A., Garcia-Rudaz C., Paredes A., Mayer C., Mayerhofer A., Ojeda S. R., Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans. Endocrinology 2009 150 6 2906 2914 2-s2.0-66649126063 10.1210/en.2008-1575
93. Dissen G. A., Lara H. E., Leyton V., Paredes A., Hill D. F., Costa M. E., Martinez-Serrano A., Ojeda S. R., Intraovarian excess of nerve growth factor increases androgen secretion and disrupts estrous cyclicity in the rat. Endocrinology 2000 141 3 1073 1082 2-s2.0-0034463958 10.1210/en.141.3.1073 (Pubitemid 32260450)
94. Vink J. M., Sadrzadeh S., Lambalk C. B., Boomsma D. I., Heritability of polycystic ovary syndrome in a Dutch twin-family study. The Journal of Clinical Endocrinology and Metabolism 2006 91 6 2100 2104 2-s2.0-33744956385 10.1210/jc.2005-1494 (Pubitemid 43854989)
95. Kosova G., Urbanek M., Genetics of the polycystic ovary syndrome. Molecular and Cellular Endocrinology 2013 373 1-2 29 38
96. Acupuncture NINCDPo, Acupuncture. The Journal of the American Medical Association 1998 280 1518 1524
97. Witt C. M., Pach D., Brinkhaus B., Wruck K., Tag B., Mank S., Willich S. N., Safety of acupuncture: results of a prospective observational study with 229,230 patients and introduction of a medical information and consent form. Forschende Komplementarmedizin 2009 16 2 91 97 2-s2.0-67649202460 10.1159/000209315
98. Zhang H., Bian Z., Lin Z., Are acupoints specific for diseases? A systematic review of the randomized controlled trials with sham acupuncture controls. Chinese Medicine 2010 5, article 1 2-s2.0-76749143692 10.1186/1749-8546-5-1
99. Moffet H. H., Sham acupuncture may be as efficacious as true acupuncture: a systematic review of clinical trials. Journal of Alternative and Complementary Medicine 2009 15 3 213 216 2-s2.0-62649122915 10.1089/acm.2008. 0356
100. Jansen G., Lundeberg T., Kjartansson J., Samuelson U. E., Acupuncture and sensory neuropeptides increase cutaneous blood flow in rats. Neuroscience Letters 1989 97 3 305 309 2-s2.0-0024496462 (Pubitemid 19047476)
101. Holmäng A., Mimura K., Lönnroth P., Involuntary leg movements affect interstitial nutrient gradients and blood flow in rat skeletal muscle. Journal of Applied Physiology 2002 92 3 982 988 2-s2.0-0036092718 (Pubitemid 34670951)
102. Blom M., Lundeberg T., Dawidson I., Angmar-Månsson B., Effects on local blood flux of acupuncture stimulation used to treat xerostomia in patients suffering from Sjögren's syndrome. Journal of Oral Rehabilitation 1993 20 5 541 548 2-s2.0-0027671053
103. Sandberg M., Lundeberg T., Lindberg L.-G., Gerdle B., Effects of acupuncture on skin and muscle blood flow in healthy subjects. European Journal of Applied Physiology 2003 90 1-2 114 119 2-s2.0-0242720263 (Pubitemid 37369502)
104. Dawidson I., Angmar-Månsson B., Blom M., Theodorsson E., Lundeberg T., The influence of sensory stimulation (acupuncture) on the release of neuropeptides in the saliva of healthy subjects. Life Sciences 1998 63 8 659 674 2-s2.0-0031602572 10.1016/S0024-3205(98)00317-8 (Pubitemid 28378334)
105. Sato A., Sato Y., Shimura M., Uchida S., Calcitonin gene-related peptide produces skeletal muscle vasodilation following antidromic stimulation of unmyelinated afferents in the dorsal root in rats. Neuroscience Letters 2000 283 2 137 140 2-s2.0-0034616059 10.1016/S0304-3940(00)00932-0 (Pubitemid 30156752)
106. Zhang G. G., Yu C., Lee W., Lao L., Ren K., Berman B. M., Involvement of peripheral opioid mechanisms in electroacupuncture analgesia. Explore 2005 1 5 365 371 2-s2.0-33745498034 10.1016/j.explore.2005.06.006 (Pubitemid 43960636)
107. Kaufman M. P., Waldrop T. G., Rybicki K. J., Ordway G. A., Mitchell J. H., Effects of static and rhythmic twitch contractions on the discharge of group III and IV muscle afferents. Cardiovascular Research 1984 18 11 663 668 2-s2.0-0021717286 (Pubitemid 15202682)
108. Yamamoto H., Kawada T., Kamiya A., Miyazaki S., Sugimachi M., Involvement of the mechanoreceptors in the sensory mechanisms of manual and electrical acupuncture. Autonomic Neuroscience 2011 160 1-2 27 31 2-s2.0-79551539842 10.1016/j.autneu.2010.11.004
109. Han J.-S., Physiology of acupuncture: review of thirty years of research. Journal of Alternative and Complementary Medicine 1997 3 1 S-101 S-108 2-s2.0-0000632336 (Pubitemid 127531558)
110. Kagitani F., Uchida S., Hotta H., Aikawa Y., Manual acupuncture needle stimulation of the rat hindlimb activates groups I, II, III and IV single afferent nerve fibers in the dorsal spinal roots. Japanese Journal of Physiology 2005 55 3 149 155 2-s2.0-28544439511 10.2170/jjphysiol.R2120 (Pubitemid 41745715)
111. Stener-Victorin E., Kobayashi R., Kurosawa M., Ovarian blood flow responses to electro-acupuncture stimulation at different frequencies and intensities in anaesthetized rats. Autonomic Neuroscience 2003 108 1-2 50 56 2-s2.0-0242495280 10.1016/j.autneu.2003.08.006 (Pubitemid 37386263)
112. Stener-Victorin E., Fujisawa S., Kurosawa M., Ovarian blood flow responses to electroacupuncture stimulation depend on estrous cycle and on site and frequency of stimulation in anesthetized rats. Journal of Applied Physiology 2006 101 1 84 91 2-s2.0-33745850085 10.1152/japplphysiol.01593.2005 (Pubitemid 44035352)
113. Pomeranz B., Chiu D., Naloxone blockade of acupuncture analgesia: endorphin implicated. Life Sciences 1976 19 11 1757 1762 2-s2.0-0017028798 (Pubitemid 8004353)
114. Mayer D. J., Price D. D., Rafii A., Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone. Brain Research 1977 121 2 368 372 2-s2.0-0017348057 10.1016/0006-8993(77)90161-5 (Pubitemid 8025529)
115. Cheng R. S. S., Pomeranz B., Electroacupuncture analgesia could be mediated by at least two pain-relieving mechanisms; endorphin and non-endorphin systems. Life Sciences 1979 25 23 1957 1962 2-s2.0-0018569852 10.1016/0024-3205(79)90598-8 (Pubitemid 10168030)
116. Yao T., Andersson S., Thoren P., Long-lasting cardiovascular depressor response following sciatic stimulation in spontaneously hypertensive rats. Evidence for the involvement of central endorphin and serotonin systems. Brain Research 1982 244 2 295 303 2-s2.0-0019970225 10.1016/0006-8993(82)90088-9 (Pubitemid 12044570)
117. Fichna J., Janecka A., Costentin J., Do Rego J.-C., The endomorphin system and its evolving neurophysiological role. Pharmacological Reviews 2007 59 1 88 123 2-s2.0-33847366597 10.1124/pr.59.1.3 (Pubitemid 46333997)
118. Zhao Z.-Q., Neural mechanism underlying acupuncture analgesia. Progress in Neurobiology 2008 85 4 355 375 2-s2.0-48349135601 10.1016/j.pneurobio.2008. 05.004
119. Akil H., Watson S. J., Young E., Lewis M. E., Khachaturian H., Walker J. M., Endogenous opioids: biology and function. Annual Review of Neuroscience 1984 7 223 255 2-s2.0-0021288895 (Pubitemid 14155298)
120. Andersson S., Lundeberg T., Acupuncture-from empiricism to science functional background to acupuncture effects in pain and disease. Medical Hypotheses 1995 45 3 271 281 2-s2.0-0028846878 10.1016/0306-9877(95)90117-5
121. Jenkins P. J., Grossman A., The control of the gonadotrophin releasing hormone pulse generator in relation to opioid and nutritional cues. Human Reproduction 1993 8 supplement 2 154 161 2-s2.0-0027449405 (Pubitemid 23337197)
122. Yao T., Andersson S., Thoren P., Long-lasting cardiovascular depression induced by acupuncture-like stimulation of the sciatic nerve in unanaesthetized spontaneously hypertensive rats. Brain Research 1982 240 1 77 85 2-s2.0-0020069254 10.1016/0006-8993(82)90645-X (Pubitemid 12129274)
123. Young E. A., Lewis J., Akil H., The preferential release of beta-endorphin from the anterior pituitary lobe by corticotropin releasing factor (CRF). Peptides 1986 7 4 603 607 2-s2.0-0022501659 (Pubitemid 16015807)
124. Eyvazzadeh A. D., Pennington K. P., Pop-Busui R., Sowers M., Zubieta J.-K., Smith Y. R., The role of the endogenous opioid system in polycystic ovary syndrome. Fertility and Sterility 2009 92 1 1 12 2-s2.0-67649103570 10.1016/j.fertnstert.2009.05.012
125. Clement-Jones V., McLoughlin L., Tomlin S., Besser G. M., Rees L. H., Wen H. L., Increased β -endorphin but not metenkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. The Lancet 1980 2 8201 946 949 2-s2.0-0019185092
126. Lee H.-J., Lee J.-H., Lee E.-O., Lee H.-J., Kim K.-H., Kim S.-H., Lee K.-S., Jung H.-J., Kim S.-H., Substance P and beta-endorphin mediate electro-acupuncture induced analgesia in mouse cancer pain model. Journal of Experimental & Clinical Cancer Research 2009 28 1, article 102 2-s2.0-69049089844 10.1186/1756-9966-28-102
127. Ahsin S., Saleem S., Bhatti A. M., Iles R. K., Aslam M., Clinical and endocrinological changes after electro-acupuncture treatment in patients with osteoarthritis of the knee. Pain 2009 147 1-3 60 66 2-s2.0-70449646233 10.1016/j.pain.2009.08.004
128. Stener-Victorin E., Jedel E., Janson P. O., Sverrisdottir Y. B., Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome. American Journal of Physiology 2009 297 2 R387 R395 2-s2.0-68049100394 10.1152/ajpregu.00197.2009
129. Yao T., Andersson S., Thoren P., Long-lasting cardiovascular depression induced by acupuncture-like stimulation of the sciatic nerve in unanaesthetized spontaneously hypertensive rats. Brain Research 1982 240 1 77 85 2-s2.0-0020069254 10.1016/0006-8993(82)90645-X (Pubitemid 12129274)
130. Yao T., Andersson S., Thoren P., Long-lasting cardiovascular depressor response to somatic stimulation in spontaneously hypertensive rats. Acta Physiologica Scandinavica 1981 111 1 109 111 2-s2.0-0019524332 (Pubitemid 11146323)
131. Ciechanowska M., Łapot M., Mateusiak K., Przekop F., Neuroendocrine regulation of GnRH release and expression of GnRH and GnRH receptor genes in the hypothalamus-pituitary unit in different physiological states. Reproductive Biology 2010 10 2 85 124 2-s2.0-77957030547
132. Kimura F., Funabashi T., Two subgroups of gonadotropin-releasing hormone neurons control gonadotropin secretion in rats. News in Physiological Sciences 1998 13 5 225 231 2-s2.0-0032360577
133. Smith M. J., Jennes L., Neural signals that regulate GnRH neurones directly during the oestrous cycle. Reproduction 2001 122 1 1 10 2-s2.0-0034912210 (Pubitemid 32677143)
134. Thoren P., Floras J. S., Hoffmann P., Seals D. R., Endorphins and exercise: physiological mechanisms and clinical implications. Medicine and Science in Sports and Exercise 1990 22 4 417 428 2-s2.0-0025315063 (Pubitemid 20241706)
135. Rivier C., Rivest S., Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biology of Reproduction 1991 45 4 523 532 2-s2.0-0026042459
136. Xiao-Peng M., Tan L.-Y., Yang Y., Wu H.-G., Jiang B., Liu H.-R., Yang L., Effect of electro-acupuncture on substance P, its receptor and corticotropin-releasing hormone in rats with irritable bowel syndrome. World Journal of Gastroenterology 2009 15 41 5211 5217 2-s2.0-73449103544 10.3748/wjg.15.5211
137. Sherman K. J., Cherkin D. C., Ichikawa L., Avins A. L., Delaney K., Barlow W. E., Khalsa P. S., Deyo R. A., Treatment expectations and preferences as predictors of outcome of acupuncture for chronic back pain. Spine 2010 35 15 1471 1477 2-s2.0-77954887364 10.1097/BRS.0b013e3181c2a8d3
138. Näslund J., Lundeberg T., Lund I., Sing A., Is placebo acupuncture what it is intended to be? Evidence-Based Complementary and Alternative Medicine 2011 2011 5 2-s2.0-80052756441 10.1093/ecam/nep049 932407
139. Lund I., Näslund J., Lundeberg T., Minimal acupuncture is not a valid placebo control in randomised controlled trials of acupuncture: a physiologist's perspective. Chinese Medicine 2009 4, article 1 2-s2.0-61349187733 10.1186/1749-8546-4-1
140. Zangeneh F. Z., Mohammadi A., Ejtemaeimehr S., Naghizadeh M. M., Fatemeh A., The role of opioid system and its interaction with sympathetic nervous system in the processing of polycystic ovary syndrome modeling in rat. Archives of Gynecology and Obstetrics 2011 283 4 885 892 2-s2.0-79955936962 10.1007/s00404-010-1776-7
141. Aleem F. A., McIntosh T., Elevated plasma levels of β -endorphin in a group of women with polycystic ovarian disease. Fertility and Sterility 1984 42 5 686 689 2-s2.0-0021689539 (Pubitemid 15202319)
142. Wortsman J., Wehrenberg W. B., Gavin J. R. III, Allen J. P., Elevated levels of plasma β -endorphin and γ 3-melanocyte stimulating hormone in the polycystic ovary syndrome. Obstetrics and Gynecology 1984 63 5 630 634 2-s2.0-0021338639 (Pubitemid 14143913)
143. Fruzzetti F., Bersi C., Parrini D., Ricci C., Genazzani A. R., Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. Fertility and Sterility 2002 77 5 936 944 2-s2.0-0036257499 10.1016/S0015-0282(02)02955-2 (Pubitemid 34497160)
144. Ahmed M. I., Duleba A. J., El Shahat O., Ibrahim M. E., Salem A., Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome. Human Reproduction 2008 23 11 2564 2569 2-s2.0-54149098384 10.1093/humrep/den273
145. Hadžiomerović D., Rabenbauer B., Wildt L., Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women. Fertility and Sterility 2006 86 3 651 657 2-s2.0-33745180272 10.1016/j.fertnstert.2006.01.039 (Pubitemid 44307010)
146. Bo-Ying C., Jin Y., Relationship between blood radioimmunoreactive beta-endorphin and hand skin temperature during the electro-acupuncture induction of ovulation. Acupuncture and Electro-Therapeutics Research 1991 16 1-2 1 5 2-s2.0-0026086708
147. Barria A., Leyton V., Ojeda S. R., Lara H. E., Ovarian steroidal response to gonadotropins and β -adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation. Endocrinology 1993 133 6 2696 2703 2-s2.0-0027135142 10.1210/en.133.6.2696 (Pubitemid 24000722)
148. Lara H. E., Ferruz J. L., Luza S., Bustamante D. A., Borges Y., Ojeda S. R., Activation of ovarian sympathetic nerves in polycystic ovary syndrome. Endocrinology 1993 133 6 2690 2695 2-s2.0-0027131368 10.1210/en.133.6.2690 (Pubitemid 24000721)
149. Stener-Victorin E., Lundeberg T., Cajander S., Aloe L., Manni L., Waldenström U., Janson P. O., Steroid-induced polycystic ovaries in rats: effect of electro-acupuncture on concentrations of endothelin-1 and nerve growth factor (NGF), and expression of NGF mRNA in the ovaries, the adrenal glands, and the central nervous system. Reproductive Biology and Endocrinology 2003 1, article 33 2-s2.0-4344622105 10.1186/1477-7827-1-33 (Pubitemid 39130491)
150. Stener-Victorin E., Lundeberg T., Waldenstrom U., Manni L., Aloe L., Gunnarsson S., Janson P. O., Effects of electro-acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries. Biology of Reproduction 2000 63 5 1497 1503 2-s2.0-0033767158
151. Manni L., Holmäng A., Lundeberg T., Aloe L., Stener-Victorin E., Ovarian expression of alpha (1)- and beta (2)-adrenoceptors and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries. Autonomic Neuroscience 2005 118 1-2 79 87 2-s2.0-15944396826 10.1016/j.autneu.2005.01.004 (Pubitemid 40431626)
152. Manni L., Lundeberg T., Holmäng A., Aloe L., Stener-Victorin E., Effect of electro-acupuncture on ovarian expression of α (1)- and β (2)-adrenoceptors, and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries. Reproductive Biology and Endocrinology 2005 3, article 21 2-s2.0-27344444953 10.1186/1477-7827-3-21 (Pubitemid 41529036)
153. Mannerås L., Cajander S., Lönn M., Stener-Victorin E., Acupuncture and exercise restore adipose tissue expression of sympathetic markers and improve ovarian morphology in rats with dihydrotestosterone-induced PCOS. American Journal of Physiology 2009 296 4 R1124 R1131 2-s2.0-65949110339 10.1152/ajpregu.90947.2008
154. Stener-Victorin E., Waldenström U., Tägnfors U., Lundeberg T., Lindstedt G., Janson P. O., Effects of electro-acupuncture on anovulation in women with polycystic ovary syndrome. Acta Obstetricia et Gynecologica Scandinavica 2000 79 3 180 188 2-s2.0-0033993475 10.1034/j.1600-0412.2000. 079003180.x (Pubitemid 30119790)
155. Mo X., Li D., Pu Y., Xi G., Le X., Fu Z., Clinical studies on the mechanism for acupuncture stimulation of ovulation. Journal of traditional Chinese Medicine 1993 13 2 115 119 2-s2.0-0027619937
156. Feng Y., Johansson J., Shao R., Holm L. M., Billig H., Stener-Victorin E., Electrical and manual acupuncture stimulation affect oestrous cyclicity and neuroendocrine function in an 5 α -dihydrotestosterone-induced rat polycystic ovary syndrome model. Experimental Physiology 2012 97 5 651 662 2-s2.0-84860337841 10.1113/expphysiol.2011.063131
157. Hutchison S. K., Teede H. J., Rachoń D., Harrison C. L., Strauss B. J., Stepto N. K., Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome. Diabetologia 2012 55 1424 1434 2-s2.0-84855613672 10.1007/s00125-011-2442-8
158. Moran L. J., Hutchison S. K., Norman R. J., Teede H. J., Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2011 2 CD007506 2-s2.0-79953011010
159. Brawer J. R., Munoz M., Farookhi R., Development of the polycystic ovarian condition (PCO) in the estradiol valerate-treated rat. Biology of Reproduction 1986 35 3 647 655 2-s2.0-0023022734 (Pubitemid 17193935)
160. Harrison C. L., Lombard C. B., Moran L. J., Teede H. J., Exercise therapy in polycystic ovary syndrome: a systematic review. Human Reproduction Update 2011 17 2 171 183 2-s2.0-79951755056 10.1093/humupd/dmq045
161. Harrison C. L., Stepto N. K., Hutchison S. K., Teede H. J., The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome. Clinical Endocrinology 2012 76 3 351 357 2-s2.0-84856987816 10.1111/j.1365-2265.2011. 04160.x
162. Palomba S., Falbo A., Giallauria F., Russo T., Rocca M., Tolino A., Zullo F., Orio F., Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial. Human Reproduction 2010 25 11 2783 2791 2-s2.0-77958146448 10.1093/humrep/deq254
163. Huber-Buchholz M.-M., Carey D. G. P., Norman R. J., Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. The Journal of Clinical Endocrinology and Metabolism 1999 84 4 1470 1474 2-s2.0-0033346579 (Pubitemid 30644417)
164. Thomson R. L., Buckley J. D., Noakes M., Clifton P. M., Norman R. J., Brinkworth G. D., The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 2008 93 9 3373 3380 2-s2.0-51649107623 10.1210/jc.2008-0751
165. Giallauria F., Palomba S., Maresca L., Vuolo L., Tafuri D., Lombardi G., Colao A., Vigorito C., Orio F., Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS). Clinical Endocrinology 2008 69 5 792 798 2-s2.0-54049154778 10.1111/j.1365-2265. 2008.03305.x
166. Jedel E., Labrie F., Odén A., Holm G., Nilsson L., Janson P. O., Lind A.-K., Ohlsson C., Stener-Victorin E., Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial. American Journal of Physiology 2011 300 1 E37 E45 2-s2.0-78650764162 10.1152/ajpendo.00495.2010
167. Karimzadeh M. A., Javedani M., An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome. Fertility and Sterility 2010 94 1 216 220 2-s2.0-77952542933 10.1016/j.fertnstert.2009.02.078
168. Moran L. J., Pasquali R., Teede H. J., Hoeger K. M., Norman R. J., Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertility and Sterility 2009 92 6 1966 1982 2-s2.0-70749121763 10.1016/j.fertnstert.2008.09.018
169. Kiddy D. S., Hamilton-Fairley D., Bush A., Short F., Anyaoku V., Reed M. J., Franks S., Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clinical Endocrinology 1992 36 1 105 111 2-s2.0-0026543775
170. Randeva H. S., Lewandowski K. C., Drzewoski J., Brooke-Wavell K., O'Callaghan C., Czupryniak L., Hillhouse E. W., Prelevic G. M., Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 2002 87 10 4496 4501 2-s2.0-0036775651 10.1210/jc.2001-012056 (Pubitemid 35247032)
171. Pastore L. M., Williams C. D., Jenkins J., Patrie J. T., True and sham acupuncture produced similar frequency of ovulation and improved LH to FSH ratios in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 2011 96 10 3143 3150 2-s2.0-80053520385 10.1210/jc.2011-1126
172. Stener-Victorin E., Waldenström U., Tägnfors U., Lundeberg T., Lindstedt G., Janson P. O., Effects of electro-acupuncture on anovulation in women with polycystic ovary syndrome. Acta Obstetricia et Gynecologica Scandinavica 2000 79 3 180 188 2-s2.0-0033993475 10.1034/j.1600-0412.2000. 079003180.x (Pubitemid 30119790)
173. Johansson J., Redman L., Veldhuis P. P., Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial. American Journal of Physiology Endocrinology and Metabolism 2013 304 9 E934 E943
174. Legro R. S., Barnhart H. X., Schlaff W. D., Carr B. R., Diamond M. P., Carson S. A., Steinkampf M. P., Coutifaris C., McGovern P. G., Cataldo N. A., Gosman G. G., Nestler J. E., Giudice L. C., Leppert P. C., Myers E. R., Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. The New England Journal of Medicine 2007 356 6 551 566 2-s2.0-33846875851 10.1056/NEJMoa063971 (Pubitemid 46220816)
175. Mannerås L., Jonsdottir I. H., Holmäng A., Lönn M., Stener-Victorin E., Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome. Endocrinology 2008 149 7 3559 3568 2-s2.0-46349104851 10.1210/en.2008-0053 (Pubitemid 351919588)
176. Johansson J., Feng Y., Shao R., Lönn M., Billig H., Stener-Victorin E., Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome. American Journal of Physiology 2010 299 4 E551 E559 2-s2.0-77957566703 10.1152/ajpendo.00323.2010
177. Teede H. J., Misso M. L., Deeks A. A., Moran L. J., Stuckey B. G. A., Wong J. L. A., Norman R. J., Costello M. F., Guideline Development Groups G. D. G., Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. The Medical Journal of Australia 2011 195 6 S65 S112 2-s2.0-84856379035
178. Tarlatzis B. C., Fauser B. C. J. M., Legro R. S., Norman R. J., Hoeger K., Pasquali R., Franks S., Messinis I. E., Casper R. F., Homburg R., Lobo R., Rebar R. W., Fleming R., Carr B. R., Bouchard P., Chang J., Hugues J. N., Azziz R., Kolibianakis E. M., Griesinger G., Diedrich K., Balen A., Farquhar C., Devroey P., Ho P. C., Collins J., Goulis D. G., Eijkemans R., Crosignani P. G., DeCherney A., Van Steirteghem A., Consensus on infertility treatment related to polycystic ovary syndrome. Human Reproduction 2008 23 3 462 477 2-s2.0-40749085240 10.1093/humrep/dem426 (Pubitemid 351651223)
179. Homburg R., Clomiphene citrate-end of an era? A mini-review. Human Reproduction 2005 20 8 2043 2051 2-s2.0-25144483568 10.1093/humrep/dei042 (Pubitemid 41418487)
180. Costello M. F., Misso M. L., Wong J., The treatment of infertility in polycystic ovary syndrome: a brief update. Australian and New Zealand Journal of Obstetrics and Gynaecology 2012 52 400 403
181. Imani B., Eijkemans M. J. C., te Velde E. R., Habbema J. D. F., Fauser B. C. J. M., Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. The Journal of Clinical Endocrinology and Metabolism 1998 83 7 2361 2365 2-s2.0-0031758855 10.1210/jc.83.7.2361 (Pubitemid 28503028)
182. Palomba S., Falbo A., Zullo F., Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance. Current Opinion in Obstetrics & Gynecology 2009 21 6 465 473 2-s2.0-77950472933
183. Farquhar C., Lilford R. J., Marjoribanks J., Vandekerckhove P., Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2007 3 CD001122 2-s2.0-35348842650
184. Feng Y., Johansson J., Shao R., Mannerås L., Fernandez-Rodriguez J., Billig H., Stener-Victorin E., Hypothalamic neuroendocrine functions in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture. PLoS ONE 2009 4 8 2-s2.0-69949172062 10.1371/journal.pone.0006638 e6638
185. Witkin J. W., Synchronized neuronal networks: the GnRH system. Microscopy Research and Technique 1999 44 11 18 (Pubitemid 29019613)
186. Plant T. M., A comparison of the neuroendocrine mechanisms underlying the initiation of the preovulatory LH surge in the human, Old World monkey and rodent. Frontiers in Neuroendocrinology 2012 33 160 168 2-s2.0-84858725755 10.1016/j.yfrne.2012.02.002
187. Rogers M.-C., Silverman A.-J., Gibson M. J., Gonadotropin-releasing hormone axons target the median eminence: in vitro evidence for diffusible chemoattractive signals from the mediobasal hypothalamus. Endocrinology 1997 138 9 3956 3966 2-s2.0-0030744677 10.1210/en.138.9.3956 (Pubitemid 27351952)
188. Skynner M. J., Sim J. A., Herbison A. E., Detection of estrogen receptor α and β messenger ribonucleic acids in adult gonadotropin-releasing hormone neurons. Endocrinology 1999 140 11 5195 5201 2-s2.0-0033303528
189. Maeda K.-I., Adachi S., Inoue K., Ohkura S., Tsukamura H., Metastin/Kisspeptin and control of estrous cycle in rats. Reviews in Endocrine and Metabolic Disorders 2007 8 1 21 29 2-s2.0-34047196781 10.1007/s11154-007- 9032-6 (Pubitemid 46536849)
190. Foecking E. M., Szabo M., Schwartz N. B., Levine J. E., Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator. Biology of Reproduction 2005 72 6 1475 1483 2-s2.0-18844378644 10.1095/biolreprod.105.039800 (Pubitemid 40696090)
191. Foecking E. M., Levine J. E., Effects of experimental hyperandrogenemia on the female rat reproductive axis: suppression of progesterone-receptor messenger RNA expression in the brain and blockade of luteinizing hormone surges. Gender Medicine 2005 2 3 155 165 2-s2.0-28244436487 10.1016/S1550- 8579(05)80044-0 (Pubitemid 41700278)
192. Foecking E. M., McDevitt M. A., Acosta-Martínez M., Horton T. H., Levine J. E., Neuroendocrine consequences of androgen excess in female rodents. Hormones and Behavior 2008 53 5 673 692 2-s2.0-42749090715 10.1016/j.yhbeh.2007. 12.013
193. Rossmanith W. G., Keckstein J., Spatzier K., Lauritzen C., The impact of ovarial laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease. Clinical Endocrinology 1991 34 3 223 230 2-s2.0-0026127280
194. Martikainen H., Ronnberg L., Ruokonen A., Kauppila A., Gonadotropin pulsatility in a stimulated cycle: clomiphene citrate increases pulse amplitudes of both luteinizing hormone and follicle-stimulating hormone. Fertility and Sterility 1991 56 4 641 645 2-s2.0-0025954243